Manufacturer of Controlled Substances; Notice of Application; Sigma Aldrich Research Biochemicals, Inc.

Federal Register, Volume 78 Issue 35 (Thursday, February 21, 2013)

Federal Register Volume 78, Number 35 (Thursday, February 21, 2013)

Notices

Pages 12102-12103

From the Federal Register Online via the Government Printing Office www.gpo.gov

FR Doc No: 2013-03893

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Application; Sigma Aldrich Research Biochemicals, Inc.

Pursuant to Sec. 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on November 21, 2012, Sigma Aldrich Research Biochemicals, Inc., 1-3 Strathmore Road, Natick, Massachusetts 01760-2447, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following classes of controlled substances:

------------------------------------------------------------------------

Drug Schedule

------------------------------------------------------------------------

Cathinone (1235)........................... I

Methcathinone (1237)....................... I

Page 12103

Aminorex (1585)............................ I

Alpha-ethyltryptamine (7249)............... I

Lysergic acid diethylamide (7315).......... I

Tetrahydrocannabinols (7370)............... I

4-Bromo-2,5-dimethoxyamphetamine (7391).... I

4-Bromo-2,5-dimethoxyphenethylamine (7392). I

2,5-Dimethoxyamphetamine (7396)............ I

3,4-Methylenedioxyamphetamine (7400)....... I

N-Hydroxy-3,4-methylenedioxyamphetamine I

(7402).

3,4-Methylenedioxy-N-ethylamphetamine I

(7404).

3,4-Methylenedioxymethamphetamine (MDMA) I

(7405).

Psilocybin (7437).......................... I

5-Methoxy-N,N-diisopropyltryptamine (7439). I

1-1-(2-Thienyl)cyclohexylpiperidine (TCP) I

(7470).

N-Benzylpiperazine (BZP) (7493)............ I

Heroin (9200).............................. I

Normorphine (9313)......................... I

Amphetamine (1100)......................... II

Methamphetamine (1105)..................... II

Nabilone (7379)............................ II

1-Phenylcyclohexylamine (7460)............. II

Phencyclidine (7471)....................... II

Cocaine (9041)............................. II

Codeine (9050)............................. II

Ecgonine (9180)............................ II

Levomethorphan (9210)...................... II

Levorphanol (9220)......................... II

Meperidine (9230).......................... II

Metazocine (9240).......................... II

Methadone (9250)........................... II

Morphine (9300)............................ II

Thebaine (9333)............................ II

Levo-alphacetylmethadol (9648)............. II

Remifentanil (9739)........................ II

Carfentanil (9743)......................... II

Fentanyl (9801)............................ II

------------------------------------------------------------------------

The company plans to manufacture reference standards.

Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).

Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than April 22, 2013.

Dated: February 8, 2013.

Joseph T. Rannazzisi,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

FR Doc. 2013-03893 Filed 2-20-13; 8:45 am

BILLING CODE 4410-09-P